The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
PLoS Medicine 2(4): e100-e100
Article 2005 English
Authors
RC
Robert Cockburn
PN
Paul N. Newton
EA
E. Kyeremateng Agyarko
Abstract
1 min read
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action.
Paul N. Newton, Patricia Tabernero, Prabha Dwivedi, María J. Culzoni, Marı́a Eugenia Monge, Isabel Swamidoss, Dallas C. Mildenhall, Michael D. Green, Richard W. O. Jähnke, Miguel dos Santos de Oliveira, Julia Simao, Sir Nicholas White, Facundo M. Fernández
Discussion(0)
No comments yet. Be the first to comment.